Results 171 to 180 of about 3,302 (197)

Positioning Filgotinib in the Treatment Algorithm of Moderate to Severe Ulcerative Colitis

Journal of Crohn's and Colitis, 2022
Silvio Danese, Joana Roseira, Ferdinando D'Amico   +2 more
exaly  

Efficacy and safety of filgotinib alone and in combination with methotrexate in Japanese patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: Subpopulation analyses of 24-week data of a global phase 3 study (FINCH 3)

Modern Rheumatology, 2022
Tatsuya Atsumi, Gerd-Rudiger Burmester, Eiji Sugiyama   +2 more
exaly  

ReLiFiRa (Real Life Filgotinib in Rheumatoid Arthritis): Retrospective Study of Efficacy and Safety in Common Clinical Practice

Journal of Personalized Medicine, 2023
Maurizio Benucci, Mosca Marta, Guiducci Serena   +2 more
exaly  

Filgotinib, a JAK1 Inhibitor, Has No Effect on QT Interval in Healthy Subjects

Clinical Pharmacology in Drug Development, 2020
Florence Namour
exaly  

Exposure‐response relationships for the efficacy and safety of filgotinib and its metabolite GS‐829845 in subjects with rheumatoid arthritis based on phase 2 and phase 3 studies

British Journal of Clinical Pharmacology, 2022
Cara Nelson, Amy Meng
exaly  

Dose-dependent efficacy and safety of Filgotinib in moderate to severe Crohn’s disease: a grade-assessed systematic review and meta-analysis of randomized controlled trials

European Journal of Clinical Pharmacology
M. Elgendy, Ahmed Raza, Mohamed Rifai, W. Rehman, Ahmed Emara, Muhammad Haris Khan, Ayiz Jan, Muhammad Younas, Anum Nawaz, Ubaid Khan   +9 more
semanticscholar   +1 more source

Corticosteroid-Sparing Effects of Filgotinib in Moderately to Severely Active Ulcerative Colitis: Data from the Phase 2b/3 SELECTION Study

Journal of Crohn's and Colitis, 2023
Edward Loftus, Severine Vermeire, William Sandborn   +2 more
exaly  

Filgotinib decreases both vertebral body and posterolateral spine inflammation in ankylosing spondylitis: results from the TORTUGA trial

Rheumatology, 2022
Robert Landewé, Walter Maksymowych, Robin Besuyen   +2 more
exaly  

Filgotinib Induces and Maintains Ulcerative Colitis Remission

JAMA, 2021
openaire   +2 more sources

The Relative Bioavailability and Effects of Food and Acid‐Reducing Agents on Filgotinib Tablets in Healthy Subjects

Clinical Pharmacology in Drug Development, 2019
Florence Namour
exaly